Cross infection with Streptococcus pneumoniae through a resuscitaire.

S. Mehtar,Y. Drabu,S. Vijeratnam,F. Mayet

DOI: https://doi.org/10.1136/BMJ.292.6512.25

1986-01-04

British Medical Journal

Abstract:Transmission de S. pneumoniae de type 6 entre 2 nouveau-nes par une piece d'equipement de reanimation, a 48 h d'intervalle

What problem does this paper attempt to address?

FGF21 protects against ischaemia reperfusion injury in normal and fatty livers

Yong Ma,Garima Singhal,Suzanne S. Chan,Chaoqun Wang,Hongjun Yu,Bing Yin,Jing Pang,Grace Malvar,Imad Nasser,Marie L. Mather,Eleftheria Maratos‐Flier

DOI: https://doi.org/10.1111/liv.15911

IF: 8.754

2024-04-01

Liver International

Abstract:Background Liver ischaemia/reperfusion (I/R) injury, which is an inevitable clinical problem of liver resection, liver transplantation and haemorrhagic shock. Fibroblast growth factor 21 (FGF21) was intimately coupled with multiple metabolic processes and proved to protect against apoptosis and inflammatory response in hepatocytes during hepatic I/R injury. However, the regulatory mechanisms of FGF21 in hepatic I/R injury remains unknown. Therefore, we hypothesize that FGF21 protects hepatic tissues from I/R injury. Methods Blood samples were available from haemangiomas patients undergoing hepatectomy and murine liver I/R model and used to further evaluate the serum levels of FGF21 both in humans and mice. We further explored the regulatory mechanisms of FGF21 in murine liver I/R model by using FGF21‐knockout mice (FGF21‐KO mice) and FGF21‐overexpression transgenic mice (FGF21‐OE mice) fed a high‐fat or ketogenic diet. Results Our results show that the circulating levels of FGF21 were robustly decreased after liver I/R in both humans and mice. Silencing FGF21 expression with FGF21‐KO mice aggravates liver injury at 6 h after 75 min of partial liver ischaemia, while FGF21‐OE mice display alleviated hepatic I/R injury and inflammatory response. Compared with chow diet mice, exogenous FGF21 decreases the levels of aminotransferase, histological changes, apoptosis and inflammatory response in hepatic I/R injury treatment mice with a high‐fat diet. Meanwhile, ketogenic diet mice are not sensitive to hepatic I/R injury. Conclusions The circulating contents of FGF21 are decreased during liver warm I/R injury and exogenous FGF21 exerts hepatoprotective effects on hepatic I/R injury. Thus, FGF21 regulates hepatic I/R injury and may be a key therapeutic target.

gastroenterology & hepatology
FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway

Ruixue Li,Xi Liu

DOI: https://doi.org/10.1007/s12013-024-01242-8

2024-03-09

Cell Biochemistry and Biophysics

Abstract:As a predominant trigger of acute kidney injury, renal ischemia-reperfusion injury can cause permanent renal impairment, and the effective therapies are lacking. Fibroblast growth factor 21 (FGF21) plays a critical regulatory role in a variety of biological activities. This study was conducted to explore the functional of FGF21 in renal ischemia-reperfusion injury and to discuss the hidden reaction mechanism. To simulate renal ischemia-reperfusion injury in vitro, HK2 cells were induced by hypoxia/reoxygenation (H/R). The effects of FGF21 on H/R-induced HK2 cell viability were evaluated utilizing cell counting kit-8 (CCK-8). The levels of lactate dehydrogenase (LDH) and inflammatory cytokines in H/R-induced HK2 cells were assessed by means of LDH assay and enzyme-linked immunosorbent assay (ELISA). The levels of oxidative stress markers were appraised with corresponding assay kits and western blot was applied to estimate the expressions of oxidative stress-related proteins. The apoptosis of H/R-induced HK2 cells was assessed by virtue of flow cytometry. The expressions of apoptosis- and PPARγ/NF-κB signaling pathway-related proteins were evaluated with western blot. To discuss the reaction mechanism of PPARγ/NF-κB pathway in H/R-induced HK2 cells, PPARγ inhibitor GW9662 was employed to treat cells and the above experiments were then conducted again. This study found that FGF21 treatment inhibited the inflammatory response, oxidative stress and apoptosis in H/R-induced HK2 cells. Moreover, FGF21 regulated PPARγ/NF-κB signaling pathway and GW9662 partially reversed the impacts of FGF21 on the inflammatory response, oxidative stress and apoptosis in H/R-exposed HK2 cells. Collectively, FGF21 protected against H/R-induced renal tubular epithelial cell injury by regulating the PPARγ/NF-κB signaling pathway.

cell biology,biochemistry & molecular biology,biophysics
Fibroblast Growth Factor 21 Relieves Lipopolysaccharide-Induced Acute Lung Injury by Suppressing JAK2/STAT3 Signaling Pathway

Mengsi Cai,Huihui Ye,Xiayan Zhu,Xiuchun Li,Luqiong Cai,Jiajia Jin,Qiwen Chen,Yuzhe Shi,Lehe Yang,Liangxing Wang,Xiaoying Huang

DOI: https://doi.org/10.1007/s10753-023-01905-3

2023-10-23

Inflammation

Abstract:Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a life‐threatening disease without an effective drug at present. Fibroblast growth factor 21 (FGF21) was reported to be protective against inflammation in metabolic disease in recent studies. However, the role of FGF21 in ALI has been rarely investigated. In this study, it was found that the expression of FGF21 was markedly increased in lung tissue under lipopolysaccharide (LPS) stimulation in vivo , whereas it was decreased in lung epithelial cells under LPS stimulation in vitro . Therefore, our research aimed to elucidate the potential role of FGF21 in LPS-induced ALI and to detect possible underlying mechanisms. The results revealed that the deficiency of FGF21 aggravated pathological damage, inflammatory infiltration, and pulmonary function in LPS-induced ALI, while exogenous administration of FGF21 improved these manifestations. Moreover, through RNA sequencing and enrichment analysis, it was unveiled that FGF21 might play a protective role in LPS-induced ALI via JAK2/STAT3 signaling pathway. The therapeutic effect of FGF21 was weakened after additional usage of JAK2 activator in vivo . Further investigation revealed that FGF21 significantly inhibited STAT3 phosphorylation and impaired the nuclear translocation of STAT3 in vitro . In addition, the aggravation of inflammation caused by silencing FGF21 can be alleviated by JAK2 inhibitor in vitro . Collectively, these findings unveil a potent protective effect of FGF21 against LPS-induced ALI by inhibiting the JAK2/STAT3 pathway, implying that FGF21 might be a novel and effective therapy for ALI.

immunology,cell biology
Abstract P278: Fibroblast Growth Factor 21 Mediated Protection of Ischemic Myocardium

Shu Q Liu,Brandon Tefft,Alexei Kharitonenkov,Yupeng Ren,Li-Qun Zhang,Yu H Wu

DOI: https://doi.org/10.1161/res.109.suppl_1.ap278

IF: 23.213

2011-01-01

Circulation Research

Abstract:Myocardial ischemia is a prevalent disorder causing heart failure. As cardiomyocyte death is the principal cause of cardiac functional deficits, a recognized treatment is to minimize cardiomyocyte death post myocardial ischemia. While extensive investigations have been conducted, few effective cardioprotective agents have been developed for clinical applications. The goal of this investigation is to test and establish a cardioprotective agent based on fibroblast growth factor 21 (FGF21), a secretory protein participating in innate cardioprotective responses. In myocardial ischemia induced by LAD coronary artery ligation in the mouse, hepatocytes upregulated FGF21 mRNA by 11 folds at 12 hrs, followed by an increase in the FGF21 protein level in hepatocytes and the serum. Administration of recombinant FGF21 to mice immediately post MI (50 ng/gm, IV, twice/day for 3 days) resulted in a significant reduction in the fraction of myocardial infarction (MI) with reference to the LV wall volume below the LAD ligation (38+/−5 and 21+/−4%, n=7, vs. albumin administration 51+/−8 and 31+/−5%, n=6, at day 1 and 10, respectively, p<0.05 for both times) in association with improved LV dp/dt. In FGF21 overexpressing mice, the volume fraction of MI (36+/−6%, n=6) was significantly lower than that in wildtype mice (48+/−6%, n=5, p<0.05) at day 1 post MI. Furthermore, FGF21 administration to normal mice induced phosphorylation of FGFR1, PI3K, Akt, and BAD in cardiomyocytes within 10 – 30 min. These molecules were also phosphorylated in cardiomyocytes within 1 day post MI. Injection of siRNA specific to FGFR1, PI3K, or Akt to the LV anterior wall at 6 locations about 2 mm apart (diffusion range of FITC-siRNA tested by fluorescence microscopy) 3 days prior to MI resulted in a reduction in the protein level of FGFR1, PI3K, or Akt by 65+/−9, 71+/−11, or 68+/−12%, respectively (n=3), within the region of siRNA injection at 1 day post MI in association with a reduction in BAD phosphorylation and an increase in the fraction of MI by 9+/−3, 8+/−2, or 11+/−3%, respectively (n=3). These observations suggested that FGF21 contributed to myocardial protection possibly via the FGFR1-PI3K-Akt-BAD signaling mechanisms and recombinant FGF21 may be potentially used as a cardioprotective agent.
Fibroblast Growth Factor 21 Suppressed Neutrophil Extracellular Traps Induced by Myocardial Ischemia/Reperfusion Injury via Adenosine Monophosphate-Activated Protein Kinase

Ling Yun Gu,Cheng Gao Jia,Zuo Zhen Sheng,Wen Long Jiang,Zhuo Wen Xu,Wei Zhang Li,Jun You Cui,Hua Zhang

DOI: https://doi.org/10.14740/cr1705

Abstract:Background: Previous investigations have established the anti-inflammatory properties of fibroblast growth factor 21 (FGF21). However, the specific mechanism through which FGF21 mitigates myocardial ischemia/reperfusion (I/R) injury by inhibiting neutrophil extracellular traps (NETs) remains unclear. Methods: A mice model of myocardial I/R injury was induced, and myocardial tissue was stained with immunofluorescence to assess NETs. Serum NETs levels were quantified using a PicoGreen kit. In addition, the expression levels of adenosine monophosphate (AMP)-activated protein kinase (AMPK) and FGF21 were evaluated by Wes fully automated protein blotting quantitative analysis system. Moreover, a hypoxia/reoxygenation (H/R) model was established using AMPK inhibitor and agonist pretreated H9c2 cells to further explore the relationship between FGF21 and AMPK. Results: Compared with the control group, serum NETs levels were significantly higher in I/R mice, and a large number of NETs were formed in myocardial tissues (97.63 ± 11.45 vs. 69.65 ± 3.33, P < 0.05). However, NETs levels were reversed in FGF21 pretreated mice (P < 0.05). Further studies showed that FGF21 enhanced AMPK expression, which was significantly increased after inhibition of AMPK and decreased after promotion of AMPK (P < 0.05). Conclusions: FGF21 may exert cardioprotective effects by inhibiting I/R injury-induced NETs via AMPK.
A C2-symmetric chiral pool-based flexible strategy: synthesis of (+)- and (-)-shikimic acids, (+)- and (-)-4-epi-shikimic acids, and (+)- and (-)-pinitol.

Bakthavachalam Ananthan,Wan-Chun Chang,Jhe-Sain Lin,Pin-Hui Li,T. Yan

DOI: https://doi.org/10.1021/jo402764v

2014-03-21

Abstract:Via combination of a novel acid-promoted rearrangement of acetal functionality with the controlled installation of the epoxide unit to create the pivotal epoxide intermediates in enantiomerically pure form, a simple, concise, flexible, and readily scalable enantiodivergent synthesis of (+)- and (-)-shikimic acids and (+)- and (-)-4-epi-shikimic acids has emerged. This simple strategy not only provides an efficient approach to shikimic acids but also can readily be adopted for the synthesis of (+)- and (-)-pinitols. These concise total syntheses exemplify the use of pivotal allylic epoxide 14 and its enantiomer ent-14. A readily available inexpensive C2-symmetric L-tartaric acid (7) served as key precursor. In general, the strategy here provides a neat example of the use of a four-carbon chiron and offers a good account of the synthesis of functionalized cyclohexane targets.
Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1

Jiamin Li,Liling Gong,Ruijie Zhang,Sijia Li,Hang Yu,Yining Liu,Yadong Xue,Di Huang,Ning Xu,Ying Wang,Yan Xu,Yiming Zhao,Qingsui Li,Ming Li,Pengyu Li,Mingbin Liu,Zhen Zhang,Xin Li,Weijie Du,Ning Wang

DOI: https://doi.org/10.1016/j.ejphar.2021.174470

IF: 5.195

2021-11-01

European Journal of Pharmacology

Abstract:Myocardial fibrosis in post-myocardial infarction is a self-healing process of the myocardium, making ventricular remodelling difficult to reverse and develop continuously. Fibroblast growth factor 21 (FGF21) plays an essential role in cardiovascular and metabolic diseases. However, the effect and mechanism of FGF21 action on cardiac inflammation and fibrosis caused by myocardial injury have rarely been reported. Adult male Sprague–Dawley rats administered with or without recombinant human basic FGF21 (rhbFGF21) were assessed using echocardiography and haematoxylin-eosin and Masson's trichrome staining to determine the cardiac function and cardiac inflammation and fibrosis levels. FGF21 might improve cardiac electrophysiological remodelling, as characterised by a decrease in the expression of a series of inflammatory and fibrosis-related factors. Moreover, when FGR receptors (FGFRs) were blocked, the effects of FGF21 disappeared. Mechanistically, we found that oxidative stress induced the downregulation of early growth response protein 1 (EGR1), which contributed to inflammatory factors and fibrosis reduction in cardiomyocytes treated with H2O2. Collectively, FGF21 effectively suppressed the inflammation and fibrosis in post-infarcted hearts by regulating FGFR-EGR1.

pharmacology & pharmacy
FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho pathway

Tianli Xu,Qiancheng Zhu,Qun Huang,Qi Gu,Yi Zhu,Mengjie Tang,Shoujin Tian,Liming Wang,Fei Yan,Jianfei Ge,Weiping Sha,Xiaolong Lin

DOI: https://doi.org/10.1016/j.brainresbull.2023.110753

IF: 3.715

2023-09-03

Brain Research Bulletin

Abstract:Spinal cord injury (SCI) is a kind of traumatic nervous system disease caused by neuronal death, causing symptoms like sensory, motor, and autonomic nerve dysfunction. The recovery of neurological function has always been a intractable problem that has greatly distressed individuals and society. Although the involvement of iron-dependent lipid peroxidation leading to nerve cell ferroptosis in SCI progression has been reported, the underlying mechanisms remain unaddressed. Thus, this study aimed to investigate the potential of recombinant human FGF21 (rhFGF21) in inhibiting ferroptosis of nerve cells and improving limb function after SCI, along with its underlying mechanisms. In vivo animal model showed that FGFR1, p-FGFR1, and β-Klotho protein gradually increased over time after injury, reaching a peak on the third day. Moreover, rhFGF21 treatment significantly reduced ACSL4, increased GPX4 expression, reduced iron deposition, and inhibited ferroptosis. Meanwhile, rhFGF21 decreased cell apoptosis following acute spinal cord damage. In contrast, FGFR1 inhibitor PD173074 partially reversed the rhFGF21-induced therapeutic effects. Overall, this work revealed that rhFGF21 activates the FGFR1/β-Klotho pathway to decrease ferroptosis of nerve cells, suggesting that FGF21 could be a new therapeutic target for SCI neurological rehabilitation.

neurosciences
Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway

Shudong Wang,Yonggang Wang,Zhiguo Zhang,Quan Liu,Junlian Gu

DOI: https://doi.org/10.1038/cddis.2017.410

2017-08-01

Cell Death and Disease

Abstract:Doxorubicin (DOX) is a highly effective antineoplastic anthracycline drug; however, the adverse effect of the cardiotoxicity has limited its widespread application. Fibroblast growth factor 21 (FGF21), as a well-known regulator of glucose and lipid metabolism, was recently shown to exert cardioprotective effects. The aim of this study was to investigate the possible protective effects of FGF21 against DOX-induced cardiomyopathy. We preliminarily established DOX-induced cardiotoxicity models in H9c2 cells, adult mouse cardiomyocytes, and 129S1/SyImJ mice, which clearly showed cardiac dysfunction and myocardial collagen accumulation accompanying by inflammatory, oxidative stress, and apoptotic damage. Treatment with FGF21 obviously attenuated the DOX-induced cardiac dysfunction and pathological changes. Its effective anti-inflammatory activity was revealed by downregulation of inflammatory factors (tumor necrosis factor-α and interleukin-6) via the IKK/IκBα/nuclear factor-κB pathway. The anti-oxidative stress activity of FGF21 was achieved via reduced generation of reactive oxygen species through regulation of nuclear transcription factor erythroid 2-related factor 2 transcription. Its anti-apoptotic activity was shown by reductions in the number of TUNEL-positive cells and DNA fragments along with a decreased ratio of Bax/Bcl-2 expression. In a further mechanistic study, FGF21 enhanced sirtuin 1 (SIRT1) binding to liver kinase B1 (LKB1) and then decreased LKB1 acetylation, subsequently inducing AMP-activated protein kinase (AMPK) activation, which improved the cardiac inflammation, oxidative stress, and apoptosis. These alterations were significantly prohibited by SIRT1 RNAi. The present work demonstrates for the first time that FGF21 obviously prevented DOX-induced cardiotoxicity via the suppression of oxidative stress, inflammation, and apoptosis through the SIRT1/LKB1/AMPK signaling pathway.

cell biology
FGF18 alleviates hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1/Nrf2 signaling pathway in male mice

Gaozan Tong,Yiming Chen,Xixi Chen,Junfu Fan,Kunxuan Zhu,ZiJing Hu,Santie Li,Junjie Zhu,Jianjun Feng,Zhaohang Wu,Zhenyu Hu,Bin Zhou,Litai Jin,Hui Chen,Jingling Shen,Weitao Cong,XiaoKun Li

DOI: https://doi.org/10.1038/s41467-023-41800-x

IF: 16.6

2023-10-01

Nature Communications

Abstract:Hepatic ischemia-reperfusion injury (IRI) is a common complication occurs during hepatic resection and transplantation. However, the mechanisms underlying hepatic IRI have not been fully elucidated. Here, we aim to explore the role of fibroblast growth factor 18 (FGF18) in hepatic IRI. In this work, we find that Hepatic stellate cells (HSCs) secrete FGF18 and alleviates hepatocytes injury. HSCs-specific FGF18 deletion largely aggravates hepatic IRI. Mechanistically, FGF18 treatment reduces the levels of ubiquitin carboxyl-terminal hydrolase 16 (USP16), leading to increased ubiquitination levels of Kelch Like ECH Associated Protein 1 (KEAP1) and the activation of nuclear factor erythroid 2-related factor 2 (Nrf2). Furthermore, USP16 interacts and deubiquitinates KEAP1. More importantly, Nrf2 directly binds to the promoter of USP16 and forms a negative feedback loop with USP16. Collectively, our results show FGF18 alleviates hepatic IRI by USP16/KEAP1/Nrf2 signaling pathway in male mice, suggesting that FGF18 represents a promising therapeutic approach for hepatic IRI.

multidisciplinary sciences
FGF21 alleviates acute liver injury by inducing the SIRT1‐autophagy signalling pathway

Xiaoning Yang,Zhongqian Jin,Danfeng Lin,Tianzhu Shen,Jiangnan Zhang,Dan Li,Xuye Wang,Chi Zhang,Zhuofeng Lin,Xiaokun Li,Fanghua Gong

DOI: https://doi.org/10.1111/jcmm.17144

2022-01-04

Journal of Cellular and Molecular Medicine

Abstract:Liver injury can lead to different hepatic diseases, which are the mainly causes of high global mortality and morbidity. Autophagy and Sirtuin type 1 (SIRT1) have been shown protective effects in response to liver injury. Previous studies have showed that Fibroblast growth factor 21 (FGF21) could alleviate acute liver injury (ALI), but the mechanism remains unclear. Here, we verified the relationship among FGF21, autophagy and SIRT1 in carbon tetrachloride (CCl4 )-induced ALI. We established CCl4 -induced ALI models in C57BL/6 mice and the L02 cell line. The results showed that FGF21 was robustly induced in response to stress during the development of ALI. After exogenous FGF21 treatment in ALI models, liver damage in ALI mice was significantly reduced, as well as serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. Consistently, FGF21 also greatly reduced the levels of ALT, AST, pro-inflammatory cytokines interleukin 6 (IL6) and tumour necrosis factor-alpha (TNFα) in ALI cell lines. Mechanistically, exogenous FGF21 treatment efficiently upregulated the expression of autophagy marker microtubule-associated protein light chain-3 beta (LC3 II) and autophagy key molecule coiled-coil myosin-like BCL2-interacting protein (Beclin1), which was accompanied by alleviating hepatotoxicity in CCl4 -treated wild-type mice. Then, we examined how FGF21 induced autophagy expression and found that SIRT1 was also upregulated by FGF21 treatment. To further verify our results, we constructed an anti-SIRT1 lentit-RNAi to inhibit SIRT1 expression in mice and L02 cells, which reversed the protective effect of FGF21 on ALI. In summary, these results indicate that FGF21 alleviates ALI by enhancing SIRT1-mediated autophagy.

cell biology,medicine, research & experimental
FGF10 protects against particulate matter (PM)-induced lung injury via regulation of endoplasmic reticulum stress

Qiangqiang Shi,Qiang Wang,Li Liu,Junjie Chen,Beibei Wang,Saverio Bellusci,Chengshui Chen,Nian Dong

DOI: https://doi.org/10.1016/j.intimp.2022.108552

IF: 5.714

2022-04-01

International Immunopharmacology

Abstract:Exposure of the lungs to particulate matter (PM) leads to the development of respiratory disease and involves mechanisms such as oxydative stress, mitochondrial dysfunction and endoplasmic reticulum (ER) stress. However, there are no effective therapies to treat PM-induced lung diseases. Fibroblast growth factor 10 (FGF10) is a multifunctional growth factor mediating mesenchymal-to-epithelial signaling and displaying a significant therapeutic potential following injury. The present research aims to investigate the regulatory mechanism of FGF10 on ER stress in PM-induced lung injury. PM-induced lung injury leads to peribronchial wall thickening and marked infiltration of inflammatory cells which is associated with increased secretion of inflammatory cytokines. The results show that FGF10 treatment attenuates PM-induced lung injury in vivo and reversed ER stress protein GRP78 and CHOP levels. Moreover, comparison of human bronchial epithelial cells cultured with PM and FGF10 vs PM alone shows sustained cell proliferation and restrained secretion of inflammatory cytokines supporting FGF10′s protective role. Significantly, both ERK1/2 and PI3K/AKT inhibitors largely abolished the impact of FGF10 on PM-induced ER stress. Taken together, both in vivo and in vitro experiments showed that FGF10, via the activation of ERK1/2 and PI3K/AKT signaling, protects against PM-induced lung injury through the regulation of ER stress. Therefore, FGF10 represents a potential therapy for PM-induced lung injury.

pharmacology & pharmacy,immunology
FGF2 Alleviates Microvascular Ischemia-Reperfusion Injury by KLF2-mediated Ferroptosis Inhibition and Antioxidant Responses

Fanfeng Chen,Jiayu Zhan,Mi Liu,Abdullah Al Mamun,Shanshan Huang,Yibing Tao,Jiaxin Zhao,Yu Zhang,Yitie Xu,Zili He,Shenghu Du,Wei Lu,Xiaokun Li,Zimiao Chen,Jian Xiao

DOI: https://doi.org/10.7150/ijbs.85692

2023-08-21

Abstract:An essential pathogenic element of acute limb ischemia/reperfusion (I/R) injury is microvascular dysfunction. The majority of studies indicates that fibroblast growth factor 2 (FGF2) exhibits protective properties in cases of acute I/R injury. Albeit its specific role in the context of acute limb I/R injury is yet unknown. An impressive post-reperfusion increase in FGF2 expression was seen in a mouse model of hind limb I/R, followed by a decline to baseline levels, suggesting a key role for FGF2 in limb survivability. FGF2 appeared to reduce I/R-induced hypoperfusion, tissue edema, skeletal muscle fiber injury, as well as microvascular endothelial cells (ECs) damage within the limb, according to assessments of limb vitality, Western blotting, and immunofluorescence results. The bioinformatics analysis of RNA-sequencing revealed that ferroptosis played a key role in FGF2-facilitated limb preservation. Pharmacological inhibition of NFE2L2 prevented ECs from being affected by FGF2's anti-oxidative and anti-ferroptosis activities. Additionally, silencing of kruppel-like factor 2 (KLF2) by interfering RNA eliminated the antioxidant and anti-ferroptosis effects of FGF2 on ECs. Further research revealed that the AMPK-HDAC5 signal pathway is the mechanism via which FGF2 regulates KLF2 activity. Data from luciferase assays demonstrated that overexpression of HDAC5 prevented KLF2 from becoming activated by FGF2. Collectively, FGF2 protects microvascular ECs from I/R injury by KLF2-mediated ferroptosis inhibition and antioxidant responses.
Fibroblast Growth Factor 21 Dependent TLR4/MYD88/NF-κB Signaling Activation is Involved in Lipopolysaccharide-Induced Acute Lung Injury.

Jing Gao,Qiuhong Liu,Junlu Li,Chunling Hu,Wei Zhao,Wentao Ma,Mengying Yao,Lihua Xing

DOI: https://doi.org/10.1016/j.intimp.2020.106219

IF: 5.714

2020-01-01

International Immunopharmacology

Abstract:Fibroblast Growth Factor 21 (FGF21) has been reported to reduce inflammation and apoptosis. Inflammation and apoptosis are both the essential mechanisms during development of acute lung injury. This study evaluated whether pre-treatment of FGF21 could alleviate acute lung injury. Mice were pre-treated with FGF21 prior to lipopolysaccharide (LPS) treatment. 24 h later, the lung tissues and BALF were obtained to detect H&E pathology, W/D ratio, pro-inflammatory factors (TNF-alpha, IL-1 beta and IL-6) and apoptosis. In vitro, Human BEAS-2B and THP-1 cells were overexpressed with TLR4 or MYD88 or NF-kappa B plasmid to detect the inflammation or apoptosis. Data showed that FGF21 was proved to be beneficial for inhibiting inflammation and apoptosis in the LPS- induced Balb/c mice or LPS induced BEAS-2B or THP-1 cells. Furthermore, the data showed that FGF21 suppressed inflammation and apoptosis via inhibition of TLR4/MYD88/NF-kappa B signaling pathway. Therefore, FGF21 provides a possibility for the treatment of LPS induced acute lung injury.
Cardioprotective Role of Myocardial Ischemia-Induced Hepatic FGF21

Shu Q. Liu,Alexei Kharitonenkov,Li-Qun Zhang,Yu H. Wu

DOI: https://doi.org/10.1016/j.carpath.2013.01.077

IF: 3.975

2013-01-01

Cardiovascular Pathology

Abstract:Purpose: Myocardial ischemia activates innate protective mechanisms, enhancing cardiomyocyte tolerance to ischemia. Here, we demonstrate that the liver contributes to myocardial protection by up-regulating and releasing the secretory protein FGF21. Methods: Myocardial ischemia was induced in mice by ligating the LAD coronary artery. Myocardial infarction was assessed by histological assays. Left ventricular function was evaluated by echocardiography and hemodynamic analysis. The expression and activity of FGF21 and signaling molecules, including FGFR1, PI3K, Akt1, and BAD, were tested by immunoprecipitation/immunoblotting. The cardioprotective role of FGF21 was assessed in FGF21−/− and FGF21-Tg (overexpression) mice. The regulatory role of FGFR1, PI3K, and Akt1 was evaluated by siRNA-mediated gene silencing. Results: FGF21 was up-regulated in hepatocytes and serum from 0.5 to 3 days post myocardial ischemia. FGF21-/mice exhibited increased myocardial infarction, whereas FGF21-Tg mice showed reduced myocardial infarction compared to wild-type mice from 1 to 30 days, suggesting a cardioprotective role for FGF21. Administration of recombinant FGF21 to healthy mice or myocardial ischemia induced FGFR1 phosphorylation in cardiomyocytes. FGF21-/mice with myocardial ischemia exhibited reduced phosphorylation of FGFR1, PI3K, Akt1, and BAD in cardiomyocytes. siRNA-mediated FGFR1 gene silencing suppressed FGFR1 expression and reduced phosphorylation of PI3K, Akt1, and BAD, resulting in an increase in myocardial infarction. PI3K or Akt1 gene silencing reduced BAD phosphorylation and enhanced myocardial infarction, suggesting that BAD phosphorylation is required for effective cardioprotection. Conclusions: The liver contributes to myocardial protection by upregulating and releasing FGF21, and FGF21 activates the FGFR1-PI3KAkt1-BAD signaling pathway, enhancing myocardial tolerance to ischemic injury.
Research progress of fibroblast growth factor 21 on myocardial protection

Wei-Jin XIAO,Guo-Hua LI,Sun-Lin QU,Zhong REN,Zhi-Sheng JIANG

DOI: https://doi.org/10.3969/j.issn.1007-3949.2017.05.018

2017-01-01

Abstract:Fibroblast growth factor 21 (FGF21) is involved in the regulation of glucose and lipid metabolism,and is closely related to obesity,diabetes,metabolic syndrome,nonalcoholic fatty liver disease and other diseases or pathological processes.The present studies show that FGF21 can antagonize myocardial ischemia and ischemia reperfusion injury,play a significant role in myocardial protection,and its mechanism may be related to anti-apoptosis of cardiomyocyte,antiinflammation,anti-oxidative stress,regulation of myocardial cell energy metabolism and mitochondrial function,and so on.This review summarizes the research progress of myocardial protective effect of FGF21 and its mechanism.
Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway

Peng Ding,Rui Yang,Cheng Li,Hai-Long Fu,Guang-Li Ren,Pei Wang,Dong-Yu Zheng,Wei Chen,Li-Ye Yang,Yan-Fei Mao,Hong-Bin Yuan,Yong-Hua Li

DOI: https://doi.org/10.1186/s13054-023-04488-5

IF: 15.1

2023-05-23

Critical Care

Abstract:Ventilator-induced lung injury (VILI) is caused by overdistension of the alveoli by the repetitive recruitment and derecruitment of alveolar units. This study aims to investigate the potential role and mechanism of fibroblast growth factor 21 (FGF21), a metabolic regulator secreted by the liver, in VILI development.

critical care medicine
Fibroblast growth factor 21 inhibits ferroptosis following spinal cord injury by regulating heme oxygenase-1

Qi Gu,Weiping Sha,Qun Huang,Jin Wang,Yi Zhu,Tianli Xu,Zhenhua Xu,Qiancheng Zhu,Jianfei Ge,Shoujin Tian,Xiaolong Lin

DOI: https://doi.org/10.4103/1673-5374.387979

2023-11-08

Neural Regeneration Research

Abstract:Abstract JOURNAL/nrgr/04.03/01300535-202407000-00037/figure1/v/2023-11-20T171125Z/r/image-tiff Interfering with the ferroptosis pathway is a new strategy for the treatment of spinal cord injury. Fibroblast growth factor 21 can inhibit ferroptosis and promote neurofunctional recovery, while heme oxygenase-1 is a regulator of iron and reactive oxygen species homeostasis. The relationship between heme oxygenase-1 and ferroptosis remains controversial. In this study, we used a spinal cord injury rat model to show that the levels of fibroblast growth factor 21 in spinal cord tissue decreased after spinal cord injury. In addition, there was a significant aggravation of ferroptosis and a rapid increase in heme oxygenase-1 expression after spinal cord injury. Further, heme oxygenase-1 aggravated ferroptosis after spinal cord injury, while fibroblast growth factor 21 inhibited ferroptosis by downregulating heme oxygenase-1. Thus, the activation of fibroblast growth factor 21 may provide a potential treatment for spinal cord injury. These findings could provide a new potential mechanistic explanation for fibroblast growth factor 21 in the treatment of spinal cord injury.

neurosciences,cell biology
Fibroblast Growth Factor 21 Protects Against Atrial Remodeling Via Reducing Oxidative Stress.

Miao Chen,Jiawei Zhong,Zhen Wang,Hongfei Xu,Heng Chen,Xingang Sun,Yunlong Lu,Lu Chen,Xudong Xie,Liangrong Zheng

DOI: https://doi.org/10.3389/fcvm.2021.720581

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:Aim: The structural and electrical changes in the atrium, also known as atrial remodeling, are the main characteristics of atrial fibrillation (AF). Fibroblast growth factor 21 (Fgf21) is an important endocrine factor, which has been shown to play an important role in cardiovascular diseases. However, the effects of Fgf21 on atrial remodeling have not been addressed yet. The purpose of the present study is to evaluate the effects of Fgf21 on atrial remodeling. Methods and Results: Adult mice were treated with Ang II, and randomly administrated with or without Fgf21 for 2 weeks. The susceptibility to AF was assessed by electrical stimulation and optical mapping techniques. Here, we found that Fgf21 administration attenuated the inducibility of atrial fibrillation/atrial tachycardia (AF/AT), improved epicardial conduction velocity in the mice atria. Mechanistically, Fgf21 protected against atrial fibrosis and reduced oxidative stress of the atria. Consistently, in vitro study also demonstrated that Fgf21 blocked the upregulation of collagen by Tgf-β in fibroblasts and attenuated tachypacing-induced oxidative stress including reactive oxygen species (ROS), Tgf-β, and ox-CaMKII in atrial myocytes. We further found that Fgf21 attenuated oxidative stress by inducing antioxidant genes, such as SOD2 and UCP3. Fgf21 also improved tachypacing-induced myofibril degradation, downregulation of L-type calcium channel, and upregulation of p-RyR2, which implicated protective effects of Fgf21 on structural and electrical remodeling in the atria. Moreover, Nrf2 was identified as a downstream of Fgf21 and partly mediated Fgf21-induced antioxidant gene expression in atrial myocytes. Conclusion: Fgf21 administration effectively suppressed atrial remodeling by reducing oxidative stress, which provides a novel therapeutic insight for AF.
Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway

Xiaosheng Jin,Weijing Jin,Guoping Li,Jisheng Zheng,Xianrong Xu

DOI: https://doi.org/10.7717/peerj.17123

IF: 3.061

2024-03-27

PeerJ

Abstract:Background The purpose of the present study was to investigate the effect of erythropoietin (EPO) on lung ischemia-reperfusion injury (LIRI). Methods Sprague Dawley rats and BEAS-2B cells were employed to construct an ischemia-reperfusion (I/R)-induced model in vivo and in vitro , respectively. Afterward, I/R rats and tert-butyl hydroperoxide (TBHP)-induced cells were treated with different concentrations of EPO. Furthermore, 40 patients with LIRI and healthy controls were enrolled in the study. Results It was observed that lung tissue damage, cell apoptosis and the expression of BAX and caspase-3 were higher in the LIRI model in vivo and in vitro than in the control group, nevertheless, the Bcl-2, FGF23 and FGFR4 expression level was lower than in the control group. EPO administration significantly reduced lung tissue damage and cell apoptosis while also up-regulating the expression of FGF23 and FGFR4. Rescue experiments indicated that EPO exerted a protective role associated with the FGF23/FGFR4/p-ERK1/2 signal pathway. Notably, the expression of serum EPO, FGF23, FGFR4 and Bcl-2 was decreased in patients with LIRI, while the expression of caspase-3 and BAX was higher. Conclusion EPO could effectively improve LIRI, which might be related to the activation of the FGF23/FGFR4/p-ERK1/2 signaling pathway.

multidisciplinary sciences

Cross infection with Streptococcus pneumoniae through a resuscitaire.

FGF21 protects against ischaemia reperfusion injury in normal and fatty livers

FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway

Fibroblast Growth Factor 21 Relieves Lipopolysaccharide-Induced Acute Lung Injury by Suppressing JAK2/STAT3 Signaling Pathway

Abstract P278: Fibroblast Growth Factor 21 Mediated Protection of Ischemic Myocardium

Fibroblast Growth Factor 21 Suppressed Neutrophil Extracellular Traps Induced by Myocardial Ischemia/Reperfusion Injury via Adenosine Monophosphate-Activated Protein Kinase

A C2-symmetric chiral pool-based flexible strategy: synthesis of (+)- and (-)-shikimic acids, (+)- and (-)-4-epi-shikimic acids, and (+)- and (-)-pinitol.

Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1

FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho pathway

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway

FGF18 alleviates hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1/Nrf2 signaling pathway in male mice

FGF21 alleviates acute liver injury by inducing the SIRT1‐autophagy signalling pathway

FGF10 protects against particulate matter (PM)-induced lung injury via regulation of endoplasmic reticulum stress

FGF2 Alleviates Microvascular Ischemia-Reperfusion Injury by KLF2-mediated Ferroptosis Inhibition and Antioxidant Responses

Fibroblast Growth Factor 21 Dependent TLR4/MYD88/NF-κB Signaling Activation is Involved in Lipopolysaccharide-Induced Acute Lung Injury.

Cardioprotective Role of Myocardial Ischemia-Induced Hepatic FGF21

Research progress of fibroblast growth factor 21 on myocardial protection

Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway

Fibroblast growth factor 21 inhibits ferroptosis following spinal cord injury by regulating heme oxygenase-1

Fibroblast Growth Factor 21 Protects Against Atrial Remodeling Via Reducing Oxidative Stress.

Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway